Cart Details

Benlysta® Belimumab 400 Mg Injection Single-Use Vial 20 Ml

  • Manufacturer Name : Glaxo Smith Kline
  • MFG # : 49401010201
  • NDC : 49401010201
  • Distributor Name : Cardinal - SAGEBRUSH
PID UOM Price Qty
353142 1/EA Register For Member Price
634562 1EA/EA Register For Member Price
634910 1/UN Register For Member Price
Register For Member Price

 

Additional Information

Product NameBENLYSTA- belimumab injection, powder, lyophilized, for solution
Package:1 EA
J-Code:J0490 Injection, belimumab, 10 mg
Strength:400 MG
Form:Powder for Solution
NDC Number:49401010201 49401-0102-01
Generic Name:929818 929818
Brand Name:BENLYSTA
Mfg. Part No:49401-0102-01
Std Packaging:EACH
Manufacturer:GSK

Description

Indications and Usage:

BENLYSTA (belimumab) is indicated for the treatment of:

  • patients aged 5 years and older with active systemic lupus erythematosus (SLE) who are receiving standard therapy, and
  • patients aged 5 years and older with active lupus nephritis who are receiving standard therapy.

Limitations of Use:

The efficacy of BENLYSTA has not been evaluated in patients with severe active central nervous system (CNS) lupus. Use of BENLYSTA is not recommended in this situation.

Frequently Asked Questions(FAQs)

The cost of Benlysta® Belimumab 400 Mg Injection Single-Use Vial 20 Ml is $0.00 .
Benlysta® Belimumab 400 Mg Injection Single-Use Vial 20 Ml is manufactured by Glaxo Smith Kline.
Read More

Subscribe to Our Newsletter